Refractory IPA clinical trials at UCLA
1 in progress, 0 open to eligible people
Showing trials for
PC945 (Opelconazole) in Combination With Other Antifungal Therapy for the Treatment of Refractory Invasive Pulmonary Aspergillosis (OPERA-T Study)
Sorry, not currently recruiting here
To assess the safety and efficacy of nebulized PC945 in combination with systemic antifungal therapy for the treatment of refractory IPA
Los Angeles, California and other locations
Last updated: